Peginterferon alfa-2b Product Approval Information - Licensing Action

Proper name: Peginterferon alfa-2b
Tradename: PEG-Intron
Manufacturer: Schering Corp, Kenilworth, NJ, License #0994
Indication for Use: Combination therapy with Ribavirin, USP (Rebetol), for the treatment of chronic hepatitis C
Approval Date: 8/7/2001
Type of submission: Biologics license application supplement


Approval Letter (PDF)

Label (PDF)

Medication Guide (PDF)

Page Last Updated: 05/16/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English